AIMC Topic: Radiomics

Clear Filters Showing 41 to 50 of 781 articles

Predicting hematologic toxicity in advanced cervical cancer patients using interpretable machine learning models based on radiomics and dosimetrics.

BMC cancer
BACKGROUND AND OBJECTIVES: Hematologic toxicity (HT) is a common and serious side effect for advanced cervical cancer patients undergoing chemoradiotherapy. Accurately predicting HT can significantly improve patient management and treatment outcomes....

Survival risk stratification of 2021 WHO glioblastoma by MRI radiomics and biological exploration.

BMC cancer
BACKGROUND: There is variability in overall survival among 2021 World Health Organization isocitrate dehydrogenase wild type glioblastoma (IDH-wt GBM) patients. The aim of the study was to develop a combined model for stratifying survival risk in IDH...

Combining radiomics of X-rays with patient functional rating scales for predicting satisfaction after radial fracture fixation: a multimodal machine learning predictive model.

BMC musculoskeletal disorders
BACKGROUND: Patient satisfaction after one year of distal radius fracture fixation is influenced by various aspects such as the surgical approach, the patient's physical functioning, and psychological factors. Hence, a multimodal machine learning pre...

A proof of concept study of F-FDG PET/CT patient-level radiomics identify refractory/relapsed diffuse large B-cell lymphoma.

Scientific reports
This study aimed to evaluate diffuse large B-cell lymphoma (DLBCL) patients who have refractory/relapsed disease and characterize the heterogeneity of DLBCL using patient-level radiomics analysis based on F-FDG PET/CT. A total of 132 patients diagnos...

Radiomics-enhanced modelling approach for predicting the need for ECMO in ARDS patients: a retrospective cohort study.

Scientific reports
Decisions regarding veno-venous extracorporeal membrane oxygenation (vv-ECMO) in patients with acute respiratory distress syndrome (ARDS) are often based solely on clinical and physiological parameters, which may insufficiently reflect severity and h...

Deep learning and radiomics integration of photoacoustic/ultrasound imaging for non-invasive prediction of luminal and non-luminal breast cancer subtypes.

Breast cancer research : BCR
PURPOSE: This study aimed to develop a Deep Learning Radiomics integrated model (DLRN), which combines photoacoustic/ultrasound(PA/US)imaging with clinical and radiomics features to distinguish between luminal and non-luminal BC in a preoperative set...

Development of a predictive model for distant metastasis in HCC patients post-TACE using clinical data, radiomics, and deep learning.

Journal of cancer research and clinical oncology
PURPOSE: Hepatocellular carcinoma (HCC) is a perilous malignant tumor, and transcatheter arterial chemoembolization (TACE) is a widely adopted treatment technique for advanced HCC. Nevertheless, TACE may not effectively reduce the risk of distant met...

Benchmarking feature projection methods in radiomics.

Scientific reports
In radiomics, feature selection methods are primarily used to eliminate redundant features and identify relevant ones. Feature projection methods, such as principal component analysis (PCA), are often avoided due to concerns that recombining features...

Rethinking feature reproducibility in radiomics: the elephant in the dark.

European radiology experimental
In radiomics, features are often linked to biomarkers and are generally expected to be reproducible, as reproducibility is considered a prerequisite for developing predictive models in clinical applications. However, this perspective overlooks featur...

Fusion model integrating multi-sequence MRI radiomics and habitat imaging for predicting pathological complete response in breast cancer treated with neoadjuvant therapy.

Cancer imaging : the official publication of the International Cancer Imaging Society
BACKGROUND: This study aimed to develop a predictive model integrating multi-sequence MRI radiomics, deep learning features, and habitat imaging to forecast pathological complete response (pCR) in breast cancer patients undergoing neoadjuvant therapy...